Results 161 to 170 of about 138,725 (257)

JAK Inhibitors in Rheumatology: Implications for Paediatric Syndromes? [PDF]

, 2018
Sean Kerrigan, Iain B. McInnes
openalex   +1 more source

Effectiveness and Safety of a Second JAK Inhibitor in Ulcerative Colitis: The J2J Multicentre Study. [PDF]

Aliment Pharmacol Ther
Osty M, Altwegg R, Serrero M, Benezech A, Lecomte A, Cadiot G, Vuitton L, Wampach A, Nancey S, Buisson A, le Berre C, Rouillon C, Gilletta C, Goutorbe F, Fumery M, Hammoudi N, Caillo L, Vidon M, Arab N, Sickersen G, Cavicchi M, Vieujean S, Charkaoui M, Richard N, Wils P, Caron B, Amiot A, Nuzzo A, Laharie D, Kirchgesner J, Uzzan M, GETAID‐J2J group.   +31 more
europepmc   +1 more source

Successful Treatment of Cutaneous Foreign Body Granuloma with JAK Inhibitor Abrocitinib and Prednisone: A Case Report. [PDF]

Clin Cosmet Investig Dermatol
Fu J, Luo W, Wang P, Wu W, Lu J.
europepmc   +1 more source

TGF-β Inhibits IL-12-Induced Activation of Jak-STAT Pathway in T Lymphocytes [PDF]

, 1998
John J. Bright, Subramaniam Sriram
openalex   +1 more source

JAK Inhibitor Therapy

Oncology Times, 2019
openaire   +2 more sources

Polyfunctional T follicular helper cells drive checkpoint-inhibitor diabetes and are targeted by JAK inhibitor therapy. [PDF]

JCI Insight
Huang NL, Ortega JG, Kimbrell K, Lee J, Scott LN, Peluso EM, Wang SJ, Kao EY, Kim K, Olay J, Nguyen JN, Quandt Z, Angell TE, Su MA, Lechner MG.   +14 more
europepmc   +1 more source

Research Trends and Hotspots in JAK Inhibitors for Ulcerative Colitis: A Bibliometric Analysis From 2015 to 2024

Yifei Wang, Zhiying Wang, Pengfei Lou, Hong Ni, Yang Yang, Guangyao Chen, Shuxin Zhang   +6 more
openalex   +2 more sources

Characteristics of patients with myeloproliferative neoplasms with lymphoma, with or without JAK inhibitor therapy [PDF]

, 2019
Naveen Pemmaraju, Hagop M. Kantarjian, Loretta J. Nastoupil, Megan Dupuis, Lisa Zhou, Sherry Pierce, Keyur P. Patel, Lucia Masárová, Jörge E. Cortes, Srđan Verstovšek   +9 more
openalex   +1 more source

Syk-JAK Inhibitor PRT062070 [PDF]

, 2020
openaire   +1 more source

Successful Use of Upadacitinib, a Selective JAK Inhibitor, in the Treatment of Two Cases of Recalcitrant Chronic Uveitis. [PDF]

J Ophthalmic Vis Res
Dominguez D, Vaclaw S, McClard CK, Jeffries MA, Noori J.   +4 more
europepmc   +1 more source